Jianmin Liu

机构：Jingdezhen Ceramic Institute, Donghua University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Ruijin Hospital, Wuhan University, Zhongnan Hospital of Wuhan University, Jining University, First Affiliated Hospital Zhejiang University, Hubei University · ORCID：0000-0001-7009-3116

发表论文 51 篇 · 总被引 742 次 · h-index 18

代表论文

• NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia (2021 · Clinical Science · 被引 49)
• Changes in the Expression and Functional Activities of C-X-C Motif Chemokine Ligand 13 (CXCL13) in Hyperplastic Prostate (2022 · International Journal of Molecular Sciences · 被引 40)
• Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway (2021 · The Prostate · 被引 34)
• The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia (2023 · International Journal of Molecular Sciences · 被引 31)
• Glucose-regulated protein 78 modulates cell growth, epithelial–mesenchymal transition, and oxidative stress in the hyperplastic prostate (2022 · Cell Death and Disease · 被引 30)
• DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancer (2022 · Cellular Signalling · 被引 29)